Carl Icahn, one of the world’s biggest activist investors, is having trouble with two of his recent positions. The first is in Allergan and the second is in auto parts maker Federal-Mogul.
According to a report in The Wall Street Journal, Carl Icahn held just $98 million in Allergan shares as of September 30. The investor had greatly reduced his position in the company over the summer, dumping $700 million worth of shares in the company.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
While it reported that Icahn has moved the funds into increasing his stakes in Hertz Global Holdings and Herbalife, The Journal did not give a reason as to why he is pulling out of Allergan.
Meanwhile, The New York Post is reporting that Carl Icahn has failed in his attempt to acquire the auto parts maker Federal-Mogul. The investor was unable to get the company’s stockholders to agree to a $9.25-a-share buy out offer by the 4 p.m. Monday deadline. And so Icahn failed to get control of the more than 50% stock in Federal-Mogul required to take the company private.
He has, however, extended his deadline for the acquisition of the needed shares until midnight on December 15.
https://twitter.com/Carl_C_Icahn/status/798566455600095232
Carl Icahn has also been a vocal supporter of Donald Trump and is praising the President elect’s possible cabinet picks. This is in contrast to Jewish businessmen like Sheldon Adelson who seemed to only begrudgingly endorse Trump at the last minute.
He specifically endorsed Steve Mnuchin and Wilbur Ross who are are being considered for the Treasury and Commerce Departments respectively. Carl Icahn is boasting about being in direct contact with Donald Trump on these matters.
